LMDXF LumiraDx
- 0.010
- 0.0000.00%
LumiraDx News
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal
Roche, LumiraDx Deal Probed by U.K. Competition Watchdog
Express News | Cma Announced Launch of Its Merger Inquiry on Roche/Lumiradx by Notice to Parties on 23 May 2024 and Has a Deadline of 19 July 2024 for Its Phase 1 Decision
Express News | Competitiona and Market Authority: Says Start of Cma Merger Investigation: Roche / Lumiradx
CMA Invites Views From Interested Parties On Roche, LumiraDx Deal
U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx
Express News | Competition and Mkts - Merger Update : Roche / Lumiradx
News On LumiraDx Ltd. (LMDX) Now Under LMDXF
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.58%
Top Midday Decliners
US Stocks Mixed; Nasdaq Jumps Over 100 Points
12 Health Care Stocks Moving In Monday's Pre-Market Session
LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9th
LumiraDx Announces Its Securities Will Be Suspended From Trading on Nasdaq at the Open of Business on January 9th
Dow Down 100 Points; US Manufacturing PMI Falls In December
Roche (RHHBY) to Acquire LumiraDx's Point of Care Technology
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
LumiraDx Falls on Agreement With Roche to Sell Assets
Analysis
Price Target
No Data
No Data